Predictive Oncology Inc. AIPT Balance Sheet

Predictive oncology inc. (AIPT)

Balance Sheet / Quarterly

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
Current Assets:
Cash and Cash Equivalents
150	98	69	1,124	162	209	1,004	2,232	766	765	1,159	2,086	1,764	-	583	1,535	4,856	-	44	3	-	244	40	130	101	328	137	372	13	102	35	22	122	77	57	9
Certificates of deposit
-	-	-	-	-	0	0	0	244	1,224	2,693	2,693	100	-	701	1,000	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Marketable Securities
-	-	-	-	-	-	-	-	-	0	0	0	-	-	855	802	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,733	-	-	16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts Receivable
297	372	299	173	232	238	315	241	137	91	45	68	38	45	23	52	38	14	15	90	57	238	149	63	97	83	101	96	39	39	32	19	50	19	0	0
Loan Receivable Bridge Loan
-	-	-	-	-	1,815	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes Receivable (inclusive of $0 and $452,775 in advances to Helomics; net of $1,037,524 and $0 in allowances for credit losses)
-	250	250	1,801	497	163	167	167	667	785	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories
190	210	320	289	241	278	244	272	265	238	242	249	272	289	292	256	231	236	257	301	367	315	360	391	122	101	108	141	145	134	96	91	97	-	-	0
Prepaid Expense and Other Assets
160	131	154	265	318	404	275	208	289	196	188	160	148	163	221	170	271	213	202	79	190	148	149	122	60	34	35	56	27	23	66	62	30	30	44	8
Total Current Assets
798	1,062	1,094	3,654	1,451	3,109	2,007	3,122	2,371	3,302	4,328	5,258	2,608	1,708	2,677	3,818	5,397	8,197	520	474	631	947	699	708	381	547	382	667	225	299	230	195	301	127	103	17
Notes Receivable
-	-	-	-	1,112	1,134	1,112	1,112	1,070	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investment
-	-	-	-	-	-	581	1,542	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fixed Assets, net
1,507	1,633	1,769	148	180	198	184	106	87	99	109	112	101	110	121	137	139	126	147	171	196	216	204	221	158	37	12	3	3	3	4	4	4	5	5	6
Intangibles, net
3,649	4,508	4,591	950	964	973	115	115	95	96	93	95	97	97	96	94	94	92	77	79	73	72	68	67	53	52	48	140	140	140	140	140	140	141	141	141
Lease Right-of-Use Assets
729	886	1,005	333	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill
15,690	23,790	23,790	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets
22,375	31,881	32,251	5,086	3,708	5,415	4,001	5,999	3,624	3,499	4,531	5,466	2,807	1,917	2,894	4,051	5,632	8,416	745	724	900	1,236	972	997	593	636	443	810	369	443	375	340	446	274	250	165
LIABILITIES AND STOCKHOLDERS' EQUITY
Current portion of long-term debt (See Note 6)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	2	10
Current portion of convertible debt, net of discounts of $0 and $21,138 (See Note 6)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	978	378	1,081	1,156	1,206	1,227	1,055	683	663	56
Convertible Notes Payable - Related Party (See Note 9)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	597	597	-	-	-	-	-	-	-	-
Accounts Payable
3,155	3,762	3,538	432	445	409	165	186	140	74	57	79	220	648	750	791	650	1,138	2,474	2,464	2,194	1,577	1,625	1,102	1,062	636	661	612	733	723	663	728	731	719	731	768
Notes Payable – Net of Discounts of $350,426 and $1,032,813
4,795	4,470	3,808	1,812	1,634	1,004	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes Payable – Net of Discount of $352,961 and $63,028
-	-	-	1,267	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued Expenses
2,371	1,807	1,035	797	1,279	315	455	558	785	1,132	1,183	1,202	1,346	820	798	722	864	1,434	3,474	2,623	3,066	2,089	2,194	1,176	2,057	744	1,143	1,404	1,599	616	577	626	566	551	521	498
Derivative Liability
50	210	541	353	272	645	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue
40	30	29	20	23	15	18	38	6	-	-	-	7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease Liability – Net of Long-Term Portion
459	500	501	78	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short-term notes payable net of discounts of $0 and $194,097 (See Note 4)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	933	907	937	1,169	81	0	280	-	-	-	0	-	-	-	-	-	-	-
Deferred Revenue
-	-	-	-	-	-	-	-	-	10	14	14	-	5	5	5	5	29	8	71	5	5	5	69	69	5	5	15	0	-	-	-	-	-	-	-
Total Current Liabilities
10,873	10,782	9,455	4,761	3,655	-	-	-	932	1,217	1,255	1,296	-	1,473	1,554	1,519	1,519	2,602	6,889	6,066	6,203	4,842	3,905	2,347	3,469	1,385	3,385	3,007	3,414	2,495	2,447	2,581	2,353	1,955	1,919	1,333
Lease Liability
270	385	504	255	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued Expenses
-	-	-	-	-	-	-	-	-	0	77	186	-	432	555	-	0	-	-	-	213	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Liability for equity-linked financial instruments (See Note 8)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	11	15	80	149	169	87	106	165	166	87	110	14
Long-term debt and convertible debt, net of discounts of $0 and $0 (See Note 6)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	89	89	89	546	630	705	660	1,006
Accrued Expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	203	-	229	290	306	331	444	468	497	0	-	-	-	-	-	-	-
Total Liabilities
11,144	11,168	9,959	5,016	3,655	2,389	639	783	932	1,217	1,332	1,483	1,883	1,905	2,109	1,519	1,519	2,602	6,889	6,269	6,417	5,071	4,196	2,654	3,811	1,845	-	-	3,672	-	-	-	-	-	-	-
Commitments and Contingencies
-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	-	-	0	-	-	-	-	-	-	-
Stockholders’ Equity:
Convertible Preferred Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	0	-	-	-	-	-	-	-	-	-	-	-
Common Stock, $.01 par value, 100,000,000 and 50,000,000 authorized, 4,056,652 and 1,409,175 outstanding
40	31	309	173	14	133	120	118	69	62	61	64	45	34	776	532	2	-	33	31	1	29	2,228	2,222	29	2,196	1,219	1,203	1,042	986	673	386	320	291	235	140
Additional Paid-in Capital
93,653	89,590	86,882	66,296	63,146	64,297	62,138	61,622	55,636	54,114	54,040	52,277	47,894	46,257	45,231	44,657	44,584	-	-	-	30,123	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Deficit
-82,498	-68,944	-64,936	-66,401	-63,107	-61,405	-58,898	-56,525	-53,021	-51,895	-50,903	-48,360	-47,018	-46,285	-45,230	-42,668	-40,492	-	-	-	-35,641	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Other Comprehensive Income
-	-	-	-	-	-	-	-	-	0	0	0	-	-	5	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	30,935	30,320	-	29,380	26,647	26,454	25,449	23,138	17,857	17,344	14,945	14,358	11,776	9,242	8,844	6,134	5,571	5,052
Accumulated Deficit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37,113	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Deficit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35,897	-	33,245	32,099	30,333	28,697	26,543	22,568	21,392	19,291	17,573	14,718	12,582	11,868	8,901	8,246	7,382
Total Stockholders' Equity
11,231	20,713	22,291	70	53	3,026	3,361	5,215	2,691	2,281	3,199	3,982	923	11	785	2,531	4,112	5,814	-6,144	-5,544	-5,516	-3,834	-3,223	-1,656	-3,218	-1,208	-3,491	-2,844	-3,303	-2,228	-2,268	-2,953	-2,703	-2,474	-2,439	-2,189
Total Liabilities and Stockholders' Equity
22,375	31,881	32,251	5,086	3,708	5,415	4,001	5,999	3,624	3,499	4,531	5,466	2,807	1,917	2,894	4,051	5,632	-	745	724	900	1,236	972	997	593	636	443	810	369	443	375	340	446	274	250	165
Series B Convertible Preferred Stock [Member]
Convertible Preferred Stock
0	0	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series D Convertible Preferred Stock [Member]
Convertible Preferred Stock
35	35	35	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series E Convertible Preferred Stock [Member]
Convertible Preferred Stock
0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series C Convertible Preferred Stock [Member]
Preferred stock
-	-	-	-	-	-	-	-	6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-